Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Matinas BioPharma Reports Third Quarter 2023 Financial Results and Provides a Business Update
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | 8-K: Current report
Matinas BioPharma | DEF 14A: Definitive information statements
Matinas BioPharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Matinas BioPharma | 8-K: Matinas BioPharma Reports Second Quarter 2023 Financial Results and Provides a Business Update
Matinas BioPharma | S-3: Registration statement for specified transactions by certain issuers
No Data